Ifabotuzumab Phase 1 Results
Targeting EphA3 Inhibits Cancer Growth by Disrupting the Tumor Stromal Microenvironment
EphA3 Publication in 'Cancers'
Hypoxia-Controlled EphA3 Marks a Human Endometrium-Derived Multipotent Mesenchymal Stromal Cell that Supports Vascular Growth
